AAPGV - Ascentage Company Cash on Hand

Ascentage Pharma Group Ltd (AAPGV) - corporate logo

Strong confidence among hematologists in targeted developments has established a solid reputational foundation for Ascentage Pharma Group (AAPGV). Cash volume dynamics demonstrate current liquidity, where the parameter value reaches 0.16. Growth prospects are based on the licensing of small molecules to combat viruses and cancer, as well as the implementation of a unique platform designed to block tumor cell survival at the molecular level.

AAPGV - Ascentage Pharma Group International Company Cash Volume over the range 01/25/2025 - 11/21/2026

Summary analytical data breakdowns for Ascentage Pharma Group Ltd (AAPGV)

- stock value and consensus price forecast:
Fundamental valuation:AAPGV Ascentage Pharma Group Ltd
Brand item of Ascentage Pharma Group International

This indicator provides a real-time assessment of highly liquid assets that react promptly to any cash flows. The metric determines the business's ability to cover current expenses and obligations without resorting to external debt capital. For Ascentage Pharma Group (AAPGV), maintaining a sufficient liquidity buffer is critical for supporting costly clinical trials of oncology drugs. Investors should evaluate the balance between financial stability and capital efficiency. Analyzing the cash volume chart allows for the timely identification of potential liquidity gaps.

Competitor analysis for Ascentage Pharma Group

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Cash Reserve TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Company Cash Volume|Fate Therapeutics, Inc. (FATE) - Company Liquid Assets|Company Cash on Hand WHWK (Aadi Bioscience, Inc.)|Company Liquid Assets TScan Therapeutics, Inc.|Company Cash Volume CSBR (Champions Oncology Corp)|Company Total Cash Amount XBIT (XBiotech USA)|CVM - Company Cash Funds|Company Cash Balance OSTX (ostherapies.com)|Radiopharm Theranostics Ltd (RADX) - Company Cash Funds|ARTV: Company Total Cash Amount|ANL (adlainortye.com) - Company Cash Volume|VERU: Company Cash Balance|Company Cash on Hand TPST (Tempest Tx)|Company Cash on Hand Xilio XLO|Company Cash Volume RENB (Renovaro)|Company Cash Volume Mural Bio MURA|Kairos Pharma Ltd - Company Cash Volume|OnKure Therapeutics (OKUR) - Company Cash on Hand|GDTC: Company Cash Volume|Curis Inc. - Company Cash Balance|Company Cash Funds apollomicsinc.com|THAR: Company Cash Balance|Company Cash Funds Advanced Biomed Corp (ADVB)|GNPX (Genprex, Inc) - Company Cash Balance|Company Cash Volume CLDI (Calidi Biotherapeutics)|sunshinebiopharma.com (SBFM) - Company Cash Reserve|Xenetic Bio - Company Cash Volume|SLRX (Salarius Pharmaceuticals, Inc.) - Company Cash and Cash Equivalents|PPBT: Company Cash Volume|Company Cash on Hand American Oncology Network Inc|BGNE (beigene.com) - Company Cash Volume|Company Cash and Cash Equivalents CKPT (Checkpoint Therapeutics)|Company Cash on Hand ELEV (Elevation Oncology Inc.)|iCAD - Company Cash and Cash Equivalents|Ikena Oncology Inc. - Company Cash on Hand|Notable Labs Corp (NTBL) - Company Cash Reserve|VIRX: Company Cash on Hand|Company Cash Reserve morphosys.com|NAYA (NAYA Biosciences Corp) - Company Cash on Hand